PTC Therapeutics Inc
F:BH3
PTC Therapeutics Inc
F:BH3
Price:
58.86
EUR
-0.37%
Market Closed
Market Cap:
€4.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
PTC Therapeutics Inc
F:BH3
|
US |
|
A
|
Acushnet Holdings Corp
F:163
|
US |
|
Veeco Instruments Inc
NASDAQ:VECO
|
US |
|
Yue Yuen Industrial (Holdings) Ltd
HKEX:551
|
HK |
|
C
|
Ctac NV
F:TAC
|
NL |
|
F
|
First Quantum Minerals Ltd
SWB:IZ1
|
CA |
|
B
|
Brown & Brown Inc
XMUN:BTW
|
US |
|
SGS SA
F:SUVN
|
CH |
|
L
|
L'Oreal SA
BMV:ORN
|
FR |
|
Bank of China Ltd
F:W8V
|
CN |
|
T
|
Travelers Companies Inc
XMUN:PA9
|
US |
|
A
|
Alibaba Group Holding Ltd
XETRA:AHLA
|
CN |
|
V
|
Vericel Corp
XMUN:ATQP
|
US |
|
R
|
Rolls-Royce Holdings PLC
XETRA:RRU
|
UK |
|
F
|
Fluor Corp
LSE:0IQC
|
US |
|
A
|
Apple Inc
MIL:AAPL
|
US |
|
American Water Works Company Inc
NYSE:AWK
|
US |
|
A
|
Asahi Group Holdings Ltd
DUS:ABW
|
JP |
Multiples-Based Value
The Multiples-Based Value for 
PTC Therapeutics Inc (BH3) under the Base Case is hidden
EUR.
Compared with the current market price of 58.86 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BH3 Multiples-Based Value
LOCKED
